Research is vital to improving the health of the population.
Meon Health Practice is a research-active practice.
Why we carry out research
Research is critical in helping prevent, diagnose, and cure diseases. We currently have research studies which include, Asthma, Crohns, Shingles, Chronic Kidney Disease, and Atrial Fibrillation.
When you participate in a clinical trial you are making a huge contribution and potentially helping many other people.
What is involved
Taking part in a research study can vary greatly and might involve completing a questionnaire, agreeing to an interview with a researcher, or taking part in a clinical trial.
- Our healthcare professionals may talk to you about a particular study and ask if you would be interested in participating.
- We may send you information via post or text message if you are suitable for that area of our research
- Participation in research is voluntary. You can choose not to participate and doing so will not impact on the medical care we provide you.
How research may help you
Our Research team will keep you updated on your progress and how the study is doing. This can help you to learn more about your health.
- Research improves services and treatments, not just for you but also for future generations.
- Your contribution can help the development of new tests for diagnosis, treatments and processes.
- Being part of the research may help to give you a more positive outlook with any health issues.
We will be inviting patients to participate in the OPTIMISE2 Study (June 2025)
The OPTIMISE2 study explores the best way to adjust blood pressure (BP) medicines for older adults. It includes patients aged 75+, on two or more BP medications with controlled BP, who are at higher risk of side effects (e.g., falls) or are frail.
Many older adults on multiple medications face increased risk of adverse drug reactions (ADRs) and hospitalisation . BP drugs, while preventive, might harm frail individuals . OPTIMISE2 investigates if safely reducing these medicines is beneficial and cost-effective, lowering ADRs without increasing serious heart problems .
This randomised study has an Intervention Group that will gradually stop one or more BP medicines under GP supervision to maintain safe BP . The Control Group continues usual care . Participants have a 4-week safety check-up, with other health data from electronic health records .
Exclusions include recent (within 6 months) heart attack/stroke, specific heart failure, or essential current medication . Active follow-up lasts one year , with potential passive follow-up via health records for up to 3, 5, or 10 years if successful . This research aims for a safer, more effective BP management for older populations.
Our Research Team
We have a dedicated Research Team led by Dr. Rem Lee.
Clinical Research Nurse Barbara Watkins is available to talk to about our research and answer any questions you may have. She is usually available on Thursday and Friday mornings at our Highlands surgery.
Further information
If you would like to know more about research studies, visit the NIHR Be Part Of Research website.